Osteoarthritis: State of the Art

  • H. R. SchumacherJr.


Osteoarthritis (OA), the most common of the diseases of human joints, is probably best considered as a response to a number of different pathogenetic factors that vary from patient to patient. The end result of these factors is degeneration of articular cartilage. This produces characteristic clinical features including joint pain largely on motion or weight bearing, crepitus, and limitation of motion without systemic features. At a 1985 workshop attempts at formulating a uniform definition were made, but unanimity was not attained [9].


Joint Space Narrowing Diffuse Idiopathic Skeletal Hyperostosis Homogentisic Acid Synovial Lining Cell Cartilage Fragment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ali SY, Griffiths S (1983) Formation of calcium phosphate crystals in normal and osteoarthritis cartilage. Ann Rheum Dis 42 (Suppl):45–48PubMedCrossRefGoogle Scholar
  2. 2.
    Cheung HS, McCarty DJ (1982) Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured synovial cells. Arthritis Rheum 25:76Google Scholar
  3. 3.
    Eymontt MJ, Gordon GV, Schumacher HR (1982) The effects on synovial permeability and synovial fluid Leukocyte counts in symptomatic osteoarthritis after intraarticular corticosteroid administration. J Rheumatol 9:198–203PubMedGoogle Scholar
  4. 4.
    Gibilisco PA, Schumacher HR, Hollander JL, et al. (1985) Synovial fluid crystals in osteoarthritis. Arthritis Rheum 28:511–515PubMedCrossRefGoogle Scholar
  5. 5.
    Halverson PE, McCarty DJ (1986) Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. Ann Rheum Dis 45:603–605PubMedCrossRefGoogle Scholar
  6. 6.
    Kellgren JH, Lawrence JS (1958) Osteoarthrosis and disk degeneration in an urban population. Ann Rheum Diss 17:388–397CrossRefGoogle Scholar
  7. 7.
    Kellgren JH, Moore H (1952) Generalized osteoarthritis and Heberden’s nodes. Br Med J 1:181–187PubMedCrossRefGoogle Scholar
  8. 8.
    Lindblad S, Hedfors E (1987) Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 30:1081–1088PubMedCrossRefGoogle Scholar
  9. 9.
    Mankin HJ, Brandt KD (1986) Workshop on etiopathogenesis of osteoarthritis. J Rheumatol 13:1127–1160Google Scholar
  10. 10.
    Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ (1984) Osteoarthritis. Saunders, Philadelphia, p 585Google Scholar
  11. 11.
    Paul H, Reginato AJ, Schumacher HR (1983) Alizarin red S staining as a screening test to detect calcium compounds in synovial fluid. Arthritis Rheum 26:191–200PubMedCrossRefGoogle Scholar
  12. 12.
    Pelletier J-P, Martel-Pelletier J, Ghandur-Minaymneh L, et al. (1985) Role of synovial membrane inflammation in cartilage breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 28:554PubMedCrossRefGoogle Scholar
  13. 13.
    Resnick D, Shapiro RF, Wiesner KB, et al. (1978) Diffuse idiopathic skeletal hyperostosis of Forestier and Rotes-Querol. Semin Arthritis Rheum 7:153–187PubMedCrossRefGoogle Scholar
  14. 14.
    Schumacher HR (1965) Unilateral osteoarthritis of the hand. JAMA 191:246–247PubMedGoogle Scholar
  15. 15.
    Williams JM, Brandt KK (1985) Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage. Arthritis Rheum 28:1267–1278PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • H. R. SchumacherJr.

There are no affiliations available

Personalised recommendations